HAEMATO AG (XTER:HAEK) Total Stockholders Equity : €149.5 Mil (As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Total Stockholders Equity?

HAEMATO AG's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €149.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. HAEMATO AG's Book Value per Share for the quarter that ended in Jun. 2023 was €28.58. The ratio of a company's debt over equity can be used to measure how leveraged this company is. HAEMATO AG's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.02.

HAEMATO AG Total Stockholders Equity Historical Data

The historical data trend for HAEMATO AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Total Stockholders Equity Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

75.68

72.22

125.48

144.73

147.17

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial															147.99	144.73	145.59	147.17	149.45

HAEMATO AG (XTER:HAEK) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

HAEMATO AG's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(149.45	-	0)	/	5.22931
	=	28.58

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

HAEMATO AG's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.269	+	2.489)	/	149.45
	=	0.02

HAEMATO AG Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HAEK:Germany HAEK:Germany HAEK:Germany

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines